CargoAdmin, Bureaucrats, Moderators (CommentStreams), fileuploaders, Interface administrators, newuser, Push subscription managers, Suppressors, Administrators
5,230
edits
Cellular, Tissue, and Gene Therapies Advisory Committee: Difference between revisions
Cellular, Tissue, and Gene Therapies Advisory Committee (view source)
Revision as of 08:32, 31 March 2025
, 31 Marchno edit summary
(Created page with "{{Organization |OrganizationName=Cellular, Tissue, and Gene Therapies Advisory Committee |OrganizationType=Boards, Commissions, and Committees |Mission=The Cellular, Tissue, and Gene Therapies Advisory Committee provides expert advice to the FDA on the safety, effectiveness, and regulation of human cells, tissues, gene transfer therapies, and xenotransplantation products. Its mission is to ensure these therapies meet high standards of safety and efficacy for public heal...") |
No edit summary |
||
| Line 1: | Line 1: | ||
{{Organization | {{Organization | ||
|OrganizationName=Cellular, Tissue, and Gene Therapies Advisory Committee | |OrganizationName=Cellular, Tissue, and Gene Therapies Advisory Committee | ||
|OrganizationType=Boards, Commissions, and Committees | |OrganizationType=Boards, Commissions, and Committees | ||
|Mission= | |Mission=Cellular, Tissue, and Gene Therapies Advisory Committee advises FDA on safety and efficacy of therapies to ensure high standards for public health | ||
|ParentOrganization=Food and Drug Administration | |||
|TopOrganization=Department of Health and Human Services | |||
|OrganizationExecutive=Designated Federal Officer | |OrganizationExecutive=Designated Federal Officer | ||
|Services=Review of cellular therapies; gene therapy evaluations; advisory consultations | |Services=Review of cellular therapies; gene therapy evaluations; advisory consultations | ||
|Regulations=Public Health Service Act; Federal Food, Drug, and Cosmetic Act | |Regulations=Public Health Service Act; Federal Food, Drug, and Cosmetic Act | ||
|HeadquartersLocation=38. | |HeadquartersLocation=38.99583, -77.02639 | ||
|HeadquartersAddress=10903 New Hampshire Ave, Silver Spring, MD 20993 | |HeadquartersAddress=10903 New Hampshire Ave, Silver Spring, MD 20993 | ||
|Website=https://www.fda.gov/advisory-committees/cellular-tissue-and-gene-therapies-advisory-committee | |||
}} | }} | ||
'''Cellular, Tissue, and Gene Therapies Advisory Committee (CTGTAC)''' is a component of the U.S. Food and Drug Administration (FDA), located in Silver Spring, Maryland. It advises on the regulation of products involving human cells, tissues, and gene therapies, ensuring they are safe and effective for clinical use. | '''Cellular, Tissue, and Gene Therapies Advisory Committee (CTGTAC)''' is a component of the U.S. Food and Drug Administration (FDA), located in Silver Spring, Maryland. It advises on the regulation of products involving human cells, tissues, and gene therapies, ensuring they are safe and effective for clinical use. | ||